AVPR2 and polycystic kidney disease: Although much work remains to be done to fully understand the role of β3-ARs in water and salt reabsorption during sympathetic activation, the current results are potentially relevant for the development of novel pharmacologic approaches to the treatment of diseases caused by AVPR2-altered signaling, including XNDI, polycystic kidney diseases, and the syndrome of inappropriate secretion of AVP.